Loading…
Disclosed for 16 months, Sep 2022 to Sep 2026.
Sundaram Flexi Cap Fund is an active equity fund in the Flexi Cap category from Sundaram Mutual Fund. In July 2026 it disclosed 54 stocks worth ₹1,999 Cr, up ₹8.6 Cr from Jun 2026. Its largest positions were HDFC Bank Limited (6.9%), ICICI Bank Limited (6.4%), Axis Bank Limited (4.1%); the ten largest together made up 41.6% of the portfolio, and Banks was the biggest sector at 27.2% of its equity. Cash and debt stood at 1.1%. Compared with Jun 2026 the fund entered 0 new stocks and exited 0.
Top-10 weight is higher than 74% of peers
Holds more stocks than 28% of peers
Holds more cash than 7% of peers
Every line the fund disclosed, with the change against Jun 2026. Click a column to sort; click a company to see every fund that owns it.
None.
None.
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Jun 2026, the weight rose most in IT - Software (+0.9 pts) and Automobiles (+0.5 pts), and fell most in Banks (−1.0 pts) and Electrical Equipment (−0.4 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Mar 2023 | Mar 2025 | Jan 2026 | Apr 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|
| Banks | 22.7% | 27.6% | 30.2% | 28.6% | 28.2% | 27.2% |
| IT - Software | 10.2% | 6.1% | 10.4% | 6.8% | 5.8% | 6.7% |
| Automobiles | 3.8% | 5.5% | 4.3% | 4.6% | 5.3% | 5.8% |
| Industrial Products | 1.9% | — | 3.2% | 4.5% | 5.5% | 5.1% |
| Pharmaceuticals & Biotechnology | 2.3% | 5.3% | 4.6% | 3.3% | 5.0% | 4.9% |
| Cement & Cement Products | 2.9% | 3.6% | 4.8% | 4.9% | 4.8% | 4.8% |
| Construction | 3.4% | 3.8% | 3.5% | 3.7% | 4.5% | 4.2% |
| Telecom - Services | 0.9% | 3.3% | 4.5% | 4.2% | 4.0% | 4.1% |
| Petroleum Products | 7.1% | 5.1% | 4.5% | 4.6% | 3.6% | 3.6% |
| Retailing | 1.3% | 3.4% | 2.8% | 2.7% | 2.6% | 3.0% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 4 |
| 6.1% |
| 6.1% |
| 46% |
| Mar 2026 | ₹1,825 Cr | 56 | 4 | 1 | 2.3% | 2.3% | 49% |
| Feb 2026 | ₹2,059 Cr | 53 | 3 | 2 | 2.7% | 2.7% | 48% |
| Jan 2026 | ₹2,051 Cr | 52 | 10 | 9 | 4.6% | 4.6% | 49% |
| Sep 2025 | ₹2,064 Cr | 51 | 14 | 28 | 3.6% | 3.6% | 48% |
| Mar 2025 | ₹1,957 Cr | 65 | 15 | 14 | 3.9% | 3.9% | 30% |
| Sep 2024 | ₹2,256 Cr | 64 | 13 | 12 | 2.1% | 2.1% | 21% |
| Mar 2024 | ₹2,105 Cr | 63 | 9 | 13 | 1.5% | 1.5% | 39% |
| Sep 2023 | ₹2,089 Cr | 67 | 22 | 22 | 0.7% | 0.7% | 34% |
| Mar 2023 | ₹1,847 Cr | 67 | 16 | 1 | 6.7% | 6.7% | 42% |
| Sep 2022 | ₹1,732 Cr | 52 | 33.8% | 33.8% | 43% |